These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3039076)

  • 1. Cardiac function as related to adrenergic activity in hypertensive left ventricular hypertrophy.
    Agabiti-Rosei E; Muiesan ML; Romanelli G; Castellano M; Beschi M; Alicandri C; Muiesan G
    J Clin Hypertens; 1987 Jun; 3(2):203-10. PubMed ID: 3039076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic activity and myocardial anatomy and function in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1985 Dec; 3(4):S45-50. PubMed ID: 3007705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
    Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic pathways and left ventricular remodeling.
    Dorn GW
    J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
    Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low ventricular performance and high resistance in established hypertension in adults.
    Yi G; Stone S; Dao B
    J Hypertens; 1993 Nov; 11(11):1243-51. PubMed ID: 8301106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.
    Ibsen H; Julius S
    Fed Proc; 1984 Jan; 43(1):67-71. PubMed ID: 6317465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
    Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac sympathetic neuronal function in left ventricular volume and pressure overload.
    Somsen GA; Dubois EA; Brandsma K; de Jong J; van der Wouw PA; Batink HD; van Royen EA; Lie KI; van Zwieten PA
    Cardiovasc Res; 1996 Jan; 31(1):132-8. PubMed ID: 8849597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular response and red cell membrane sodium transport in hypertensive cardiac hypertrophy.
    Saito T; Kai N; Yamamoto K; Iwata J; Deguchi F; Inagaki Y
    J Hum Hypertens; 1993 Oct; 7(5):485-9. PubMed ID: 8263890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
    González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
    Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possible influence of hemodynamic and neurohormonal factors on the heart's response to arterial hypertension].
    Modena MG; Masciocco G; Mattioli G
    Cardiologia; 1994 Apr; 39(4):269-74. PubMed ID: 8062298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Data of programmed ventricular stimulation in left ventricular hypertrophy of hypertensive origin].
    Clémenty J; Coste P; Dallocchio M; Bricaud H
    Ann Cardiol Angeiol (Paris); 1989 Jun; 38(6):297-303. PubMed ID: 2527015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular mass and cardiac function in patients with essential hypertension.
    Grossman E; Oren S; Messerli FH
    J Hum Hypertens; 1994 Jun; 8(6):417-21. PubMed ID: 8089826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Remission of left ventricular hypertrophy of hypertensive origin. Experimental data].
    Contard F; Rappaport L; Samuel JL; Swynghedauw B
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():27-30. PubMed ID: 2150472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.
    Shigematsu Y; Hamada M; Mukai M; Matsuoka H; Sumimoto T; Hiwada K
    J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.